Ketotifen fumarate
- Level
- Commodity
- Parent
- 51313700
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51313709This classification denotes a histamine-1 receptor antagonist with the molecular formula C19H19NOS.C4H4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier HBD503WORO, chemically known as 4,9-dihydro-4-(1-methyl-4-piperidinylidene)-10h-benzo(4,5)cyclohepta(1,2-b)thiophen-10-one but more generally known as ketotifen fumarate, which bears US NIH Compound Identifier 3827. European Medicines Agency schedules Ketotifen fumarate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02836MIG. Most nations, for tariff and trade purposes, schedule ketotifen fumarate under HS 29349990 and SITC 51579. As of Q4 2014, KETOTIFEN FUMARATE remains US FDA's Preferred Term for this commodity. Ketotifen fumarate bears US NLM identifiers UMLS ID C0043443 and NCI Concept Code C47579. SMILES: CN1CCC(=C2C3CCCCC3CC(=O)C4C2CCS4)CC1.C(=C/C(=O)O)\C(=O)O.
Same parent
Under 51313700 · 10Activities that produce or sell this
KBLI · 9Inherited from family 51310000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.